A Pharmacokinetic Study of Synera (Lidocaine 70 mg and Tetracaine 70 mg Topical Patch) to Evaluate the Systemic Exposure to Lidocaine and Tetracaine in Neonates and Infants.

Trial Profile

A Pharmacokinetic Study of Synera (Lidocaine 70 mg and Tetracaine 70 mg Topical Patch) to Evaluate the Systemic Exposure to Lidocaine and Tetracaine in Neonates and Infants.

Suspended
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2012

At a glance

  • Drugs Lidocaine/tetracaine (Primary)
  • Indications Procedural pain
  • Focus Pharmacokinetics
  • Sponsors ZARS Pharma
  • Most Recent Events

    • 22 Mar 2012 Planned end date changed from 1 Apr 2010 to 1 Apr 2013 as reported by ClinicalTrials.gov.
    • 22 Mar 2012 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
    • 14 Oct 2009 Planned end date changed from 1 Sep 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top